Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase.
J Med Chem. 2024 Feb 22;67(4):2631-2666. doi: 10.1021/acs.jmedchem.3c01807. Epub 2024 Feb 8.
J Med Chem. 2024.
PMID: 38330278
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro).
Han SH, Goins CM, Arya T, Shin WJ, Maw J, Hooper A, Sonawane DP, Porter MR, Bannister BE, Crouch RD, Lindsey AA, Lakatos G, Martinez SR, Alvarado J, Akers WS, Wang NS, Jung JU, Macdonald JD, Stauffer SR.
Han SH, et al.
J Med Chem. 2022 Feb 24;65(4):2880-2904. doi: 10.1021/acs.jmedchem.1c00598. Epub 2021 Aug 4.
J Med Chem. 2022.
PMID: 34347470
Free PMC article.
Item in Clipboard
SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole.
Hooper A, Macdonald JD, Reilly B, Maw J, Wirrick AP, Han SH, Lindsey AA, Rico EG, Romigh T, Goins CM, Wang NS, Stauffer S.
Hooper A, et al.
Res Sq [Preprint]. 2023 May 11:rs.3.rs-2880312. doi: 10.21203/rs.3.rs-2880312/v1.
Res Sq. 2023.
PMID: 37214977
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite